Recurrent Campylobacter Bacteremia as the First Manifestation of Hypogammaglobulinemia: a Case Report and Literature Review
- PMID: 31782275
- PMCID: PMC7533215
- DOI: 10.3947/ic.2020.52.3.415
Recurrent Campylobacter Bacteremia as the First Manifestation of Hypogammaglobulinemia: a Case Report and Literature Review
Abstract
A 30-year-old woman with a past medical history of autoimmune hemolytic anemia presented with fever. Blood cultures grew Campylobacter. Her medical history was significant for four prior episodes of Campylobacter gastroenteritis and bacteremia. She received ciprofloxacin for the index presentation, then Meropenem de-escalated to doxycycline 6 months later following recurrence of Campylobacter. This prompted investigation for an immunodeficiency disorder. She was found to have hypogammaglobulinemia. Her Campylobacter infections resolved following the administration of intravenous immunoglobulins every 3 weeks. She did not have recurrence of Campylobacter during 5 years of follow-up. A literature search revealed additional four case reports of six hypogammaglobulinemic adult individuals presenting with recurrent Campylobacter infections. Three patients were already on intravenous immunoglobulin (IVIG) when Campylobacter infection occurred, and two patients achieved clinical cure following therapy with imipenem and IVIG. This case report highlights the importance of suspecting hypogammaglobulinemia in patients with recurrent Campylobacter infections, as this is sometimes the first manifestation of the condition.
Keywords: Bacteremia; Campylobacter; Hypogammaglobulinemia; Immunodeficiency.
Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Conflict of interest statement
No conflicts of interest.
References
-
- Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T, Kassenborg H, Reilly K, Kennedy M, Angulo F, Tauxe RV Emerging Infections Program FoodNet Working Group. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004;38(Suppl 3):S165–S174. - PubMed
-
- Iovine NM. Innate immunity in Campylobacter infections. In: Namchampkin I, Szymanski CM, Blaser MJ, editors. Campylobacter. 3rd ed. Washington, DC: American Society for Microbiology; 2008. pp. 333–350. - DOI
-
- Blaser MJ, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In: Namchampkin I, Szymanski CM, Blaser MJ, editors. Campylobacter. 3rd ed. Washington, DC: American Society of Microbiology; 2008. pp. 99–111.
-
- Fernández-Cruz A, Muñoz P, Mohedano R, Valerio M, Marín M, Alcalá L, Rodriguez-Créixems M, Cercenado E, Bouza E. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) 2010;89:319–330. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
